Divergent sustainability profiles of molnupiravir synthesis routes are governed by solvent use and process design
{{output}}
This study presents a comparative cradle-to-gate environmental and economic evaluation of nine synthetic routes for Molnupiravir (EIDD-2801), a broad-spectrum antiviral drug. Integrating Life Cycle Assessment (LCA) with Life Cycle Costing (LCC), we quantified ... ...
